Health effects of tobacco

2021 Insights on the Head & Neck Cancers Global Market - Epidemiology Forecasts to 2035 - ResearchAndMarkets.com

Retrieved on:

Friday, July 9, 2021

Pharmaceutical, Health, Oncology, Otorhinolaryngology, Health effects of tobacco, Head and neck cancer, Cancer, Health, Causes of death, Carcinogens, Infectious causes of cancer, Head and Neck Cancer Alliance, HPV-positive oropharyngeal cancer

The "Global Head & Neck Cancers Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Global Head & Neck Cancers Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.
The research report provides Head & Neck Cancers epidemiology, demographics, and patient flow.
The research provides population data to characterize Head & Neck Cancers patients, history of the disease at the population level (Head & Neck Cancers prevalence, Head & Neck Cancers incidence) and at the clinical level (from diagnosis to treated patients).
Head & Neck Cancers patient flow: Head & Neck Cancers prevalence, diagnosed, and drug-treated patients
Demographics: Head & Neck Cancers patients by age group, gender
The data from this research will help executives:
Establish basis for Head & Neck Cancers market sizing, assessing market potential, and developing drug forecast models
Identify Head & Neck Cancers patients segments through age groups, gender, and disease sub-types
Evaluate Head & Neck Cancers market opportunities, identify target patient population
View source version on businesswire.com: https://www.businesswire.com/news/home/20210709005291/en/

Kaival Brands (OTCQB:KAVL) Announces Bidi Vapor to Resume Attendance at Live Trade Shows as Vaccination Rates Rise

Retrieved on:

Thursday, July 8, 2021

Tobacco, Electronic cigarettes, Smoking, Health effects of tobacco, Smoking cessation, Electronic cigarette, Bidi

Kaival Brands is the exclusive global distributor of products manufactured by Bidi Vapor, including the BIDI Stick disposable electronic nicotine delivery system ("ENDS"), which is intended exclusively for adults 21 and over.

Key Points:

Kaival Brands is the exclusive global distributor of products manufactured by Bidi Vapor, including the BIDI Stick disposable electronic nicotine delivery system ("ENDS"), which is intended exclusively for adults 21 and over.
"As COVID-19 restrictions loosen, Bidi Vapor and Kaival Brands are happy to return to a more face-to-face form of marketing," says Niraj Patel, president and Chief Executive Officer of Kaival Brands.
Bidi Vapor executives and sales personnel are scheduled to attend the following business-to-business ("B2B") trade events:
VOXPO Vape Live (virtual), London, England; July 28-30, 2021; Visit https://voxpoevents.com/event/vape-live/ .
As a result, Bidi Vapor and the Company are considered under common control and Bidi Vapor is considered a related party.

Decibel Announces Strategic Partnership to Bring US Brand Dabstract, and Exclusive Product Formulations to Canada

Retrieved on:

Wednesday, July 7, 2021

Tobacco, Electronic cigarettes, Smoking, Health effects of tobacco, Electronic cigarette, Smoking cessation, Strategic partnership, Brand

Under the strategic partnership, Decibel has gained access to unique product formulations and intellectual property for the manufacturing of vapes and concentrates.

Key Points:

Under the strategic partnership, Decibel has gained access to unique product formulations and intellectual property for the manufacturing of vapes and concentrates.
This partnership allows Decibel to acquire the exclusive right to produce these distinct product formulations for its existing brands, as well as, to manufacture and distribute UCG's branded products under the Dabstract brand.
"This strategic partnership bolsters our product development pipeline in the high growth vape and concentrate product categories while strengthening our brand portfolio by bringing the renowned Dabstract brand to the Canadian marketplace."
"We look forward to helping Decibel grow the concentrate and vape categories in Canada with our manufacturing expertise and Dabstract brand."

VAPORESSO Parent Company SMOORE International Listed on Forbes 2021 Global 2000

Retrieved on:

Thursday, July 1, 2021

Tobacco, Electronic cigarettes, Smoking, Health effects of tobacco, Smoking cessation, Electronic cigarette, Forbes, Shenzhen

SHENZHEN, China, July 01, 2021 (GLOBE NEWSWIRE) -- The parent company behind globally renowned vaping brand VAPORESSO , SMOORE International Holdings (HKG:6969), has officially been listed on Forbes 2021 Global 2000 .

Key Points:

SHENZHEN, China, July 01, 2021 (GLOBE NEWSWIRE) -- The parent company behind globally renowned vaping brand VAPORESSO , SMOORE International Holdings (HKG:6969), has officially been listed on Forbes 2021 Global 2000 .
SMOORE is the only vaping technology company to make the Forbes 2021 Global 2000 list.
SMOORE International appearing on the list gives credibility to both the company and the emerging vaping industry.
Supported by parent company, R&D giant SMOORE International, Vaporesso has been setting new industry standards and further driving innovation in this emerging industry with many more to come.

Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2a Study of EMB-001 in Smoking Cessation

Retrieved on:

Wednesday, June 30, 2021

Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for cocaine, nicotine, and potentially other addictions, today announced that the first subject has been dosed in a Phase 2a smoking cessation study for the treatment of tobacco use disorder.

Key Points:

Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for cocaine, nicotine, and potentially other addictions, today announced that the first subject has been dosed in a Phase 2a smoking cessation study for the treatment of tobacco use disorder.
In a Phase 1 Safety study, EMB-001 was well-tolerated and signals of efficacy were observed.
This Phase 2a study will help us better understand the efficacy of EMB-001 in helping subjects stop smoking.
Current investors in Embera participated in a $1.3 million financing to support the EMB-001 Phase 2a tobacco use disorder clinical study.

IGNITE Provides Corporate Update

Retrieved on:

Monday, June 28, 2021

IGNITE International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) (IGNITE or the Company), a global consumer packaged goods brand, today provided a corporate update of its activities for 2021.

Key Points:

IGNITE International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) (IGNITE or the Company), a global consumer packaged goods brand, today provided a corporate update of its activities for 2021.
Ignite will be handling the sales for the book with a substantial portion of the book revenue expected to go to Ignite.
Now that the book is finished and the pandemic is winding down, Dan plans to be more actively engaged in promoting Ignite and his lifestyle brand.
IGNITE product categories include CBD products, nicotine and synthetic nicotine vape products, premium performance drinks named ZRO, spirits featuring a premium vodka and tequila, and apparel.

CEL-SCI’s Multikine® Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit (62.7% Vs 48.6%) in the Group Receiving Surgery Plus Radiotherapy in a Landmark Head and Neck Cancer Phase 3 Study

Retrieved on:

Monday, June 28, 2021

This group represents about 155,000 patients worldwide, or about 40% of all advanced primary head and neck cancer cases annually.

Key Points:

This group represents about 155,000 patients worldwide, or about 40% of all advanced primary head and neck cancer cases annually.
The chemotherapy, cisplatin, was given intravenously and may have negated the survival benefit imparted by Multikine immunotherapy in these patients.
The two main comparator arms of the study were: the Multikine treatment regimen (Multikine plus CIZ: cyclophosphamide; indomethacin; zinc-multivitamins) plus SOC vs. SOC alone.
In each of these comparator arms, patients were determined by pathology following surgery to receive radiotherapy only or concurrent radio-chemotherapy.

SLANG Worldwide Creates Third Core Market with Signing of Definitive Merger Agreement to Acquire High Fidelity, Vermont's Largest Vertically Integrated Operation

Retrieved on:

Monday, June 28, 2021

Tobacco, Smoking, Health effects of tobacco, Electronic cigarettes, Electronic cigarette, Smoking cessation

Merger includes retail, distribution and cultivation capabilities in the limited license market where adult-use sales are expected to reach up to US$230 million in 2023[1]

Key Points:

In addition to the four dispensaries, HI-FI operates statewide home delivery services and wholesale distribution of its own branded products as well as SLANG branded products.
HI-FI has a long-standing mutually beneficial relationship with SLANG as a licensed manufacturer and distributor of leading vape brand, O.pen, in Vermont since 2015.
Additionally, the Merger is expected to lead to the introduction of more of SLANG's award-winning, market-leading brands (District Edibles, Firefly, Bakked and Lunchbox Alchemy) to the Vermont market.
Pursuant to the Merger Agreement, SLANG may issue additional SLANG Shares upon the achievement of certain performance milestones.

Global E-Cigarettes and Vapor Products Markets 2021-2025: Shifting Consumer Perception Towards Combustible Smoking & Swelling Demand for Ashless and Smokeless Vaping Alternatives - ResearchAndMarkets.com

Retrieved on:

Friday, June 25, 2021

Tobacco, Retail, Electronic cigarettes, Tobacco, Smoking, Health effects of tobacco, Electronic cigarette, Cigarette, Usage of electronic cigarettes, Safety of electronic cigarettes

This report provides an in-depth analysis of the global e-cigarettes and vapor products market by value, by product, by composition, by battery mode, by region, etc.

Key Points:

This report provides an in-depth analysis of the global e-cigarettes and vapor products market by value, by product, by composition, by battery mode, by region, etc.
The report also provides a detailed analysis of the COVID-19 impact on the e-cigarettes and vapor products market.
The e-cigarettes and vapor products market can be segmented on the basis of product, named as open tank, rechargeable, closed tank and disposable.
The e-cigarettes and vapor products market is expected to increase due to increase in Gen Z income, increasing influence of social media, growing penetration of e-commerce, shifting consumer perception towards combustible cigarettes, swelling demand for ashless and smokeless vaping alternatives and growing urbanization.

This 4th of July Declare Your Independence from Tobacco

Retrieved on:

Thursday, June 24, 2021

Psychoactive drugs, Nicotinic agonists, Smoking, Health effects of tobacco, Electronic cigarettes, Leaves, Tobacco, Nicotine, Smoking cessation, Electronic cigarette and e-cigarette liquid marketing, Nicotine Anonymous

"Empowering tobacco users to measure their own nicotine levels is like dieters measuring their weight loss.

Key Points:

"Empowering tobacco users to measure their own nicotine levels is like dieters measuring their weight loss.
For a limited time, with My Nicotine Testing tobacco consumers will receive tobacco treatment counseling without charge.
Without new and improved ways to engage the user, tobacco is expected to kill 1 billion people this century" he continued.
A health care professional-facing app is also available separately at the App Store for clinicians to help their tobacco using patients.